A systematic review of adherence with medications for diabetes

被引:892
作者
Cramer, JA [1 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA
关键词
D O I
10.2337/diacare.27.5.1218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The purpose of this study was to determine the extent to which patients omit doses of medications prescribed for diabetes. RESEARCH DESIGN AND METHODS - A literature search (1966-2003) was performed to identify reports with quantitative data on adherence with oral hypoglycemic agents (OHAs) and insulin and correlations between adherence rates and glycemic control. Adequate documentation of adherence was found in 15 retrospective studies of OHA prescription refill rates, 5 prospective electronic monitoring OHA studies, and 3 retrospective insulin studies. RESULTS - Retrospective analyses showed that adherence to OHA therapy ranged from 36 to 93% in patients remaining on treatment for 6-24 months. Prospective electronic monitoring studies documented that patients took 67-85% of OHA doses as prescribed. Electronic monitoring identified poor compliers for interventions that improved adherence (61-79%; P < 0.05). Young patients filled prescriptions for one-third of prescribed insulin doses. Insulin adherence among patients with type 2 diabetes was 62-64%. CONCLUSIONS - This review confirms that many patients for whom diabetes medication was prescribed were poor compliers with treatment, including both OHAs and insulin. However, electronic monitoring systems were useful in improving adherence for individual patients. Similar electronic monitoring systems for insulin administration could help healthcare providers determine patients needing additional support.
引用
收藏
页码:1218 / 1224
页数:7
相关论文
共 42 条
  • [1] Persistence of use of lipid-lowering medications - A cross-national study
    Avorn, J
    Monette, J
    Lacour, A
    Bohn, RL
    Monane, M
    Mogun, H
    LeLorier, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1458 - 1462
  • [2] Utilization of oral hypoglycemic agents in a drug-insured US population
    Boccuzzi, SJ
    Wogen, J
    Fox, J
    Sung, JCY
    Shah, AB
    Kim, J
    [J]. DIABETES CARE, 2001, 24 (08) : 1411 - 1415
  • [3] Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus
    Brown, JB
    Nichols, GA
    Glauber, HS
    Bakst, A
    [J]. CLINICAL THERAPEUTICS, 1999, 21 (06) : 1045 - 1057
  • [4] Electronic compliance monitoring in resistant hypertension:: the basis for rational therapeutic decisions
    Burnier, M
    Schneider, MP
    Chioléro, A
    Stubi, CLF
    Brunner, HR
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (02) : 335 - 341
  • [5] Predictors of persistence of use of the novel antidiabetic agent acarbose
    Catalan, VS
    Couture, JA
    LeLorier, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (08) : 1106 - 1112
  • [6] Depression and diabetes -: Impact of depression symptoms on adherence, function, costs
    Ciechanowski, PS
    Katon, WJ
    Russo, JE
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) : 3278 - 3285
  • [7] A systematic review of the associations between dose regimens and medication compliance
    Claxton, AJ
    Cramer, J
    Pierce, C
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (08) : 1296 - 1310
  • [8] Cramer J.A., 1995, AM J MANAG CARE, V1, P45
  • [9] MICROELECTRONIC SYSTEMS FOR MONITORING AND ENHANCING PATIENT COMPLIANCE WITH MEDICATION REGIMENS
    CRAMER, JA
    [J]. DRUGS, 1995, 49 (03) : 321 - 327
  • [10] Cramer JA, 1998, AM J MANAG CARE, V4, P1563